Enteral Nutrition Market: Surging Valuation to $12,294 Million by 2027 with a Strong CAGR of 7.1%

The enteral nutrition market, with a valuation of $6,762 million in 2018, is poised for remarkable growth and is expected to reach a staggering $12,294 million by the year 2027. This projection signifies a substantial Compound Annual Growth Rate (CAGR) of 7.1% from 2020 to 2027. These figures underscore the immense potential and lucrative nature of the enteral nutrition industry, reflecting the increasing demand for specialized nutrition solutions.

Over the forecast period, the enteral nutrition market is set to experience sustained expansion driven by various factors. The rising prevalence of chronic diseases, such as gastrointestinal disorders, cancer, and neurological disorders, has necessitated the use of enteral nutrition as an essential part of medical treatments. Furthermore, advancements in healthcare infrastructure, especially in developing regions, are enhancing access to enteral nutrition products and boosting market growth.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐒𝐚𝐦𝐩𝐥𝐞: https://www.alliedmarketresearch.com/request-sample/5049

Key Market Players

B. BRAUN MELSUNGEN AG, HORMEL FOODS CORPORATION, ABBOTT LABORATORIES, NESTLE S.A, MEIJI HOLDINGS CO., LTD., VICTUS, INC., FRESENIUS KABI AG, DANONE S.A., RECKITT BENCKISER GROUP PLC., GLOBAL HEALTH PRODUCTS, INC.

𝐓𝐡𝐞 𝐞𝐧𝐭𝐞𝐫𝐚𝐥 𝐧𝐮𝐭𝐫𝐢𝐭𝐢𝐨𝐧 𝐦𝐚𝐫𝐤𝐞𝐭 𝐜𝐚𝐧 𝐛𝐞 𝐚𝐧𝐚𝐥𝐲𝐳𝐞𝐝 𝐟𝐮𝐫𝐭𝐡𝐞𝐫 𝐛𝐚𝐬𝐞𝐝 𝐨𝐧 𝐯𝐚𝐫𝐢𝐨𝐮𝐬 𝐟𝐚𝐜𝐭𝐨𝐫𝐬 𝐬𝐮𝐜𝐡 𝐚𝐬 𝐩𝐫𝐨𝐭𝐞𝐢𝐧 𝐜𝐨𝐦𝐩𝐨𝐬𝐢𝐭𝐢𝐨𝐧, 𝐟𝐨𝐫𝐦, 𝐚𝐠𝐞 𝐠𝐫𝐨𝐮𝐩, 𝐚𝐧𝐝 𝐝𝐢𝐬𝐭𝐫𝐢𝐛𝐮𝐭𝐢𝐨𝐧 𝐜𝐡𝐚𝐧𝐧𝐞𝐥. 𝐇𝐞𝐫𝐞 𝐚𝐫𝐞 𝐭𝐡𝐞 𝐝𝐞𝐭𝐚𝐢𝐥𝐬:

1. By Protein Composition: The enteral nutrition market offers different protein compositions to cater to specific dietary needs. These categories include:
• Standard Protein Diet: This refers to enteral nutrition products that contain a balanced amount of protein suitable for general nutritional requirements.
• High Protein Supplement: These products provide a higher protein content to meet the increased protein needs of individuals with specific medical conditions or those undergoing recovery from surgery or illness.
• Protein for Diabetes Care Patients: This category focuses on enteral nutrition products designed specifically for individuals with diabetes, considering their unique dietary requirements.
• Others: This category encompasses any additional protein compositions that may target specific health conditions or nutritional needs not covered by the above classifications.
2. By Form: Enteral nutrition products are available in different forms to accommodate varying preferences and ease of consumption. The forms include:
• Powder: Enteral nutrition products in powder form require mixing with water or other liquids before consumption.
• Liquid: Ready-to-use liquid formulas are convenient for those who prefer a hassle-free solution or have difficulty preparing powdered formulas.
3. By Age Group: The enteral nutrition market caters to different age groups based on their nutritional needs. The two primary age categories are:
• Adults (Above 18): This segment includes enteral nutrition products formulated for adult patients who require nutritional support due to various medical conditions.
• Pediatric (Below 18): Enteral nutrition products for children and infants fall into this category, addressing their specific nutritional needs during growth, development, and medical treatments.
4. By Distribution Channel: The enteral nutrition market utilizes various distribution channels to reach consumers. These include:
• Hospital Sales: Enteral nutrition products are often distributed directly to hospitals and healthcare institutions to cater to patients receiving medical treatment.
• Retail: This distribution channel involves the availability of enteral nutrition products in retail stores such as pharmacies, supermarkets, and specialty health stores.
• Online: With the growth of e-commerce, many enteral nutrition products are sold online through dedicated websites, online pharmacies, and e-commerce platforms.

Leave a comment

Your email address will not be published. Required fields are marked *